Glaxosmithkline | Zinsaufwendungen Für Schuld



Interest Expense On Debt Veränderung Datum
AbbVie USD 610M 19M 2024-12
Amgen USD 747M 29M 2024-12
AstraZeneca 429M 28M 2024-12
Aurora Cannabis CAD 1.29M 768K 2024-12
Bausch Health Companies USD 346M 4M 2024-09
Bristol-Myers Squibb USD 496M 9M 2024-12
Canopy Growth CAD 16.77M 4.51M 2024-12
Corcept Therapeutics 6M 6M 2024-06
Drreddys Laboratories INR 817M 60M 2024-12
Eli Lilly USD 224.7M 78.4M 2024-12
GlaxoSmithKline 173M 17M 2024-12
Glaxosmithkline 178.05M 24.73M 2024-12
Indivior 9M 1000K 2024-09
J&J USD 137M 56M 2024-12
Merck USD 328M 2M 2024-12
Novartis USD 275M 11M 2024-12
Pacira USD 4.68M 9K 2024-12
Perrigo 43.1M 200K 2024-12
Pfizer USD 739M 45M 2024-12
Prestige Brands USD 11.37M 908K 2024-12
Roche Holding CHF 311.5M 1000K 2024-12
Sanofi 62M 17M 2024-12
Supernus Pharmaceuticals USD 0 0 2024-12
Takeda 31.6B 36.86B 2024-12
Teva Pharmaceutical Industries USD 224M 1000K 2024-12
Zoetis USD 51M 6M 2024-12



Glaxosmithkline Zinsaufwendungen Für Schuld - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.